Mateon Therapeutics Announces Positive Clinical Study Results for Its Lead Anti-Leukemia Drug Combretastatin A1 Plus Cytarabine in Adult Patients with Relapsed Acute Myeloid Leukemia

Daniel Sontupe
Market Access

Joey Cohen
Medication Adherence

Brenda Snow
Authentic Patient Voice

Stacey Gandler
Brand Nourishment

Suma Ramadas, PhD
Medical Affairs

Matthew Durham
Omnidynamic Marketing

Pat Purcell
Meeting Engagement

Amy Giles
Increasing Engagement

Frank Burrell
Scientific Storytelling

Paul Theisen
Patient Acquisition

Liz Kane
Impactful Strategy

Matt Turner
Patient Affordability

David Linetsky
Point-of-Care Marketing

Bud Bilanich
Success Coach